Earnings estimate | Current qtr. (Mar 2021) | Next qtr. (Jun 2021) | Current year (2021) | Next year (2022) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 3 | 2 |
Avg. Estimate | 0 | 0 | 2.89 | 3.15 |
Low estimate | 0 | 0 | 2.74 | 3.15 |
High estimate | 0 | 0 | 3.1 | 3.16 |
Year ago EPS | 0.96 | 0.46 | 2.97 | 2.89 |
Revenue estimate | Current qtr. (Mar 2021) | Next qtr. (Jun 2021) | Current year (2021) | Next year (2022) |
---|---|---|---|---|
No. of analysts | 2 | 2 | 4 | 3 |
Avg. Estimate | 11.9B | 11.25B | 48.52B | 50.31B |
Low estimate | 11.6B | 11.18B | 46.76B | 49.09B |
High estimate | 12.2B | 11.32B | 49.92B | 52.36B |
Year ago sales | 11.64B | N/A | 43.73B | 48.52B |
Sales growth (year/est) | 2.20% | N/A | 11.00% | 3.70% |
Earnings history | 30/03/2020 | 29/06/2020 | 29/09/2020 | 30/12/2020 |
---|---|---|---|---|
Est. EPS | 0.71 | 0.51 | 0.8 | 0.64 |
Actual EPS | 0.96 | 0.46 | 1 | 0.62 |
Difference | 0.25 | -0.05 | 0.2 | -0.02 |
Surprise % | 35.20% | -9.80% | 25.00% | -3.10% |
EPS trend | Current qtr. (Mar 2021) | Next qtr. (Jun 2021) | Current year (2021) | Next year (2022) |
---|---|---|---|---|
Current estimate | 0 | 0 | 2.89 | 3.15 |
7 days ago | 0 | 0 | 2.98 | 3.15 |
30 days ago | 0 | 0 | 3.04 | 3.24 |
60 days ago | 0 | 0 | 3.08 | 3.25 |
90 days ago | 0 | 0 | 3.07 | 3.25 |
EPS revisions | Current qtr. (Mar 2021) | Next qtr. (Jun 2021) | Current year (2021) | Next year (2022) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | 1 | N/A |
Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | -2.70% | N/A | N/A | N/A |
Next year | 9.00% | N/A | N/A | N/A |
Next 5 years (per annum) | 4.70% | N/A | N/A | N/A |
Past 5 years (per annum) | 4.75% | N/A | N/A | N/A |